Background


Maternal serum screening (MSS) and prenatal cell-free DNA (cfDNA) screening can each be used to identify fetuses at increased risk of trisomy.  A fetus usually has the same genetic makeup as the placenta, and these techniques measure components that enter the mother's bloodstream from the placenta. Therefore, results from these tests may also happen to identify confined placental mosaicism (CPM), a condition in which the genetic makeup of the fetus differs from that of the placenta. 
